These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 6955026)

  • 1. Membrane insertion and oligomeric assembly of HLA-DR histocompatibility antigens.
    Kvist S; Wiman K; Claesson L; Peterson PA; Dobberstein B
    Cell; 1982 May; 29(1):61-9. PubMed ID: 6955026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of human gamma chain with class II transplantation antigens during intracellular transport.
    Claesson L; Peterson PA
    Biochemistry; 1983 Jun; 22(13):3206-13. PubMed ID: 6576808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosynthesis and maturation of HLA-DR antigens in vivo.
    Owen MJ; Kissonerghis AM; Lodish HF; Crumpton MJ
    J Biol Chem; 1981 Sep; 256(17):8987-93. PubMed ID: 6973570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invariant chain promotes egress of poorly expressed, haplotype-mismatched class II major histocompatibility complex A alpha A beta dimers from the endoplasmic reticulum/cis-Golgi compartment.
    Layet C; Germain RN
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2346-50. PubMed ID: 1900941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DR beta chains enter into an aggregated complex containing GRP-78/BiP prior to their degradation by the pre-Golgi degradative pathway.
    Cotner T; Pious D
    J Biol Chem; 1995 Feb; 270(5):2379-86. PubMed ID: 7836473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assembly and peptide binding of major histocompatibility complex class II heterodimers in an in vitro translation system.
    Hedley ML; Urban RG; Strominger JL
    Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10479-83. PubMed ID: 7937979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation.
    Hegde NR; Tomazin RA; Wisner TW; Dunn C; Boname JM; Lewinsohn DM; Johnson DC
    J Virol; 2002 Nov; 76(21):10929-41. PubMed ID: 12368336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes.
    Lamb CA; Cresswell P
    J Immunol; 1992 Jun; 148(11):3478-82. PubMed ID: 1588042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective intracellular transport as a common mechanism limiting expression of inappropriately paired class II major histocompatibility complex alpha/beta chains.
    Sant AJ; Hendrix LR; Coligan JE; Maloy WL; Germain RN
    J Exp Med; 1991 Oct; 174(4):799-808. PubMed ID: 1919435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unassembled HLA-DR beta monomers are degraded rapidly by a nonlysosomal mechanism.
    Cotner T
    J Immunol; 1992 Apr; 148(7):2163-8. PubMed ID: 1545123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoforms of the invariant chain regulate transport of MHC class II molecules to antigen processing compartments.
    Warmerdam PA; Long EO; Roche PA
    J Cell Biol; 1996 Apr; 133(2):281-91. PubMed ID: 8609162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules.
    Elliott EA; Drake JR; Amigorena S; Elsemore J; Webster P; Mellman I; Flavell RA
    J Exp Med; 1994 Feb; 179(2):681-94. PubMed ID: 8294875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.
    Carrel S; Schmidt-Kessen A; Giuffrè L
    Eur J Immunol; 1985 Feb; 15(2):118-23. PubMed ID: 3918869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Class II histocompatibility molecules associate with calnexin during assembly in the endoplasmic reticulum.
    Schreiber KL; Bell MP; Huntoon CJ; Rajagopalan S; Brenner MB; McKean DJ
    Int Immunol; 1994 Jan; 6(1):101-11. PubMed ID: 8148318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major histocompatibility complex class II compartments in human B lymphoblastoid cells are distinct from early endosomes.
    Peters PJ; Raposo G; Neefjes JJ; Oorschot V; Leijendekker RL; Geuze HJ; Ploegh HL
    J Exp Med; 1995 Aug; 182(2):325-34. PubMed ID: 7629497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple HLA-DR antigens: detection with monoclonal antibodies and translation in vitro.
    Finn OJ; Levy R
    Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2658-62. PubMed ID: 6979750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monensin prevents terminal glycosylation of the N- and O-linked oligosaccharides of the HLA-DR-associated invariant chain and inhibits its dissociation from the alpha-beta chain complex.
    Machamer CE; Cresswell P
    Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1287-91. PubMed ID: 6608726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes simplex virus type 1 targets the MHC class II processing pathway for immune evasion.
    Neumann J; Eis-Hübinger AM; Koch N
    J Immunol; 2003 Sep; 171(6):3075-83. PubMed ID: 12960333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens.
    Henne C; Schwenk F; Koch N; Möller P
    Immunology; 1995 Feb; 84(2):177-82. PubMed ID: 7750992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and evolutionary analysis of HLA-D-region products.
    Travers P; Blundell TL; Sternberg MJ; Bodmer WF
    Nature; 1984 Jul 19-25; 310(5974):235-8. PubMed ID: 6379465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.